Management of Hypotension in Hemodialysis Patients

Introduction to Hypotension Management

• The American Journal of Kidney Diseases recommends that the most effective approach to managing intradialytic hypotension involves immediate interventions to stabilize the patient, followed by systematic modification of the dialysis prescription to prevent recurrence, with ultrafiltration rate control being the single most critical factor 1, 2

Immediate Acute Management

• Stop or reduce ultrafiltration immediately to prevent further blood pressure decline and allow vascular refilling in patients experiencing hypotension during dialysis 1, 2, 3
• Administer intravenous normal saline bolus (typically 100-250 mL) to rapidly expand plasma volume in patients with hypotension, though avoid routine saline administration for every episode as this perpetuates volume overload 2, 3
• Place the patient in Trendelenburg position (head down, legs elevated) to improve venous return and increase blood pressure in patients with hypotension 2, 3
• Provide supplemental oxygen to improve tissue oxygenation and reduce symptoms in patients with hypotension 1, 2, 3

Dialysis Prescription Modifications to Prevent Recurrence

• Keep ultrafiltration rates below 6 mL/h/kg as rates exceeding this threshold are associated with higher mortality risk and increased hypotension 3
• Extend treatment time to minimum 4 hours per session to slow the ultrafiltration rate and allow adequate vascular refilling in patients with recurrent hypotension 1, 3
• Increase dialysis frequency from twice to three times weekly when patients have excessive interdialytic weight gain requiring aggressive ultrafiltration that exceeds vascular refilling capacity 1, 3
• Reassess the estimated dry weight if hypotension is recurrent, as the target may be set too low—a common pitfall is underestimating true dry weight in patients with residual urine output 1, 2, 3

Dialysate Modifications

• Increase dialysate sodium concentration to 148 mEq/L, especially early in the dialysis session, or implement sodium profiling (starting higher and gradually decreasing) to maintain vascular stability in patients with hypotension 1, 2, 4
• Reduce dialysate temperature from 37°C to 34-35°C to increase peripheral vasoconstriction and cardiac output through increased sympathetic tone, which decreases symptomatic hypotension from 44% to 34% 1, 2, 4
• Switch from acetate-containing to bicarbonate-containing dialysate to prevent inappropriate decreases in total vascular resistance and venous pooling in patients with hypotension 1, 2, 4

Pharmacological Management

• Administer midodrine (oral α1-adrenergic agonist) 30 minutes before dialysis initiation at a mean dose of 8 mg (range 2.5-25 mg) to increase peripheral vascular resistance and enhance venous return in patients with hypotension 1, 2, 4

Medication Review

• Review and reduce antihypertensive medications, particularly when patients are on four or more concurrent agents, as these prevent compensatory vasoconstriction during ultrafiltration in patients with hypotension 3
• Consider adjusting beta-blockers like carvedilol, which blunt compensatory tachycardia and cardiac output increases needed during volume removal in patients with hypotension 3

Long-Term Prevention Strategies

• Limit sodium intake to <5.8 g/day to reduce thirst and interdialytic weight gain, as water intake adjusts to match salt intake in patients with hypotension 3
• Restrict interdialytic weight gain to <3% of body weight between sessions to prevent excessive ultrafiltration requirements in patients with hypotension 1, 3
• Avoid food intake immediately before or during hemodialysis, as this causes decreased peripheral vascular resistance and may precipitate hypotension in patients with hypotension 1, 2, 4
• Maintain hemoglobin at 11 g/dL per NKF-K/DOQI guidelines to improve oxygen-carrying capacity and cardiovascular compensation during ultrafiltration in patients with hypotension 1, 2, 3, 4

Critical Pitfalls to Avoid

• Do not continue twice-weekly dialysis in patients with recurrent hypotension, as this forces dangerously high ultrafiltration rates and inadequate solute clearance 3
• Do not routinely administer saline for every hypotensive episode, as this perpetuates volume overload and fails to address the underlying problem 3
• Do not assume hypotension defines intravascular volume status—reevaluate the estimated dry weight if patients show signs of improving nutrition (increasing serum albumin, creatinine, or normalized protein catabolic rate) alongside hypotension 1

Evidence‑Based Management of Intradialytic Hypotension

Dialysate Temperature Modification

• Reducing dialysate temperature to 34–35 °C (from the standard 37 °C) enhances peripheral vasoconstriction and cardiac output, lowering the incidence of symptomatic intradialytic hypotension from approximately 44 % to 34 %. 5

Sodium and Calcium Dialysate Adjustments

• Raising dialysate sodium to ≈148 mmol/L—either as a fixed concentration early in the session or via a sodium‑profiling strategy—helps preserve vascular stability during fluid removal. 5
• Keeping dialysate calcium at 3 mmol/L contributes to hemodynamic stability throughout the dialysis treatment. 5

Medication Review Prior to Dialysis

• Systematic review of the medication list to avoid short‑acting antihypertensives and peripheral vasodilators immediately before dialysis reduces the likelihood of intradialytic hypotension. 5

Advanced Dialysis Modalities for Refractory Cases

• Extended daily or nocturnal hemodialysis provides slower ultrafiltration rates, which may prevent activation of reflex pathways (e.g., Bezold‑Jarisch reflex) that precipitate hypotension. 5
• When all other interventions fail, referral for living‑donor kidney transplantation is recommended as a definitive therapeutic option. 5

Evidence Summary and Clinical Nuance

• Existing data suggest that high ultrafiltration rates, rather than the absolute volume removed, are the principal factor linking intradialytic hypotension to adverse outcomes; however, a direct causal relationship between hypotensive episodes and increased morbidity or mortality remains uncertain. 5

Dry Weight Reassessment in Intradialytic Hypotension Management

Assessment of Dry‑Weight Accuracy

• Reevaluate the estimated dry weight when intradialytic hypotension recurs, as the prescribed target may be set too low—particularly in patients who retain some urine output or show signs of improving nutrition (e.g., rising serum albumin or protein catabolic rate). 6

Implementation Strategy

• Determine the true dry weight gradually over a period of 4–12 weeks (or up to 6–12 months in individuals with diabetes or cardiomyopathy) by incrementally increasing ultrafiltration while avoiding hypotensive episodes. 6

Optimal Dialysis Session Duration and Ultrafiltration Strategy for Bile‑Cast Nephropathy

Session Duration

Ultrafiltration Rate Targets

Management of Hemodynamically Unstable Patients

Intradialytic Hypotension: Evidence‑Based Definition, Risk Factors, and Management

Definition and Clinical Impact

• Intradialytic hypotension (IDH) is defined as a drop in systolic blood pressure ≥ 20 mm Hg or mean arterial pressure ≥ 10 mm Hg accompanied by symptoms (abdominal discomfort, nausea, vomiting, muscle cramps, dizziness, or fainting); it occurs in ≈ 25 % of hemodialysis sessions and is linked to higher cardiovascular and all‑cause mortality, cardiac arrhythmias, vascular‑access thrombosis, and mesenteric infarction. 9

Patient‑Related Risk Factors

• Patients with diabetes mellitus and autonomic dysfunction experience exaggerated blood‑pressure declines during dialysis. 10
• Advanced age (≥ 60–65 years) impairs compensatory vascular responses, increasing IDH risk. 10
• Pre‑dialysis systolic blood pressure < 100 mm Hg, established cardiovascular disease (e.g., left‑ventricular hypertrophy, diastolic dysfunction, systolic heart failure, valvular or pericardial disease), and female sex are independent predictors of IDH. 10
• Poor nutritional status with hypoalbuminemia reduces oncotic pressure and predisposes to IDH. 10
• Severe anemia diminishes oxygen‑carrying capacity and limits cardiovascular compensation, raising IDH susceptibility. 10

Dialysis‑Related Modifiable Factors

• High interdialytic weight gain that necessitates aggressive fluid removal exceeds the vascular refilling capacity and precipitates IDH. 10
• Elevated dialysate temperature (37–38 °C) induces peripheral vasodilation and hampers compensatory vasoconstriction, increasing IDH incidence. 10, 11
• Use of acetate‑containing dialysate lowers total vascular resistance and promotes venous pooling, contributing to hypotension. 12, 13
• Inaccurate dry‑weight assessment (setting weight too low), especially in patients with improving nutrition, leads to recurrent IDH. 13, 14
• Administration of nitrates immediately before dialysis can trigger IDH. 10

Immediate Acute Management

• Placing the patient in the Trendelenburg position (head‑down, legs elevated) improves venous return and raises blood pressure during an IDH episode. 11
• Supplemental oxygen delivery during IDH improves tissue oxygenation and alleviates symptoms. 12, 15
• A rapid normal‑saline bolus of 100–250 mL can quickly expand plasma volume and raise systolic blood pressure to 100–110 mm Hg. 11
• Prior to discharge, assess for orthostatic hypotension to identify residual hemodynamic instability. 11

Preventive Strategies – Prescription Modification

• Ultrafiltration rate control: Keeping UF rates < 6 mL/h/kg (by extending session length to ≥ 4 h or increasing weekly frequency) reduces mortality risk and IDH occurrence. (Evidence from observational cohorts.)
• Isolated ultrafiltration: Sequential ultrafiltration followed by diffusive clearance, with extended total treatment time, is effective for refractory IDH. 12, 13

Preventive Strategies – Dialysate Modifications

• Temperature reduction: Lowering dialysate temperature to 34–35 °C decreases symptomatic IDH from 44 % to 34 %, enhances vascular reactivity and cardiac contractility, and does not impair urea clearance; however, it may cause mild to intolerable hypothermia in some patients. 12, 13, 14, 15, 10, 11
• Sodium profiling (sodium ramping): Raising dialysate sodium to 148 mEq/L early in the session and then gradually decreasing it stabilizes vascular tone, but may increase interdialytic weight gain and cause variable rises in interdialytic blood pressure. 12, 13, 14, 15, 16
• Buffer selection: Switching from acetate‑ to bicarbonate‑based dialysate prevents inappropriate reductions in vascular resistance and venous pooling, and reduces headaches, nausea, and vomiting. 12, 13, 14, 15, 16

Pharmacologic Prevention

• Midodrine: Administered 30 minutes before dialysis at a mean dose of 8 mg (range 2.5–25 mg) raises peripheral vascular resistance and venous return, minimizes IDH events, raises the lowest intradialytic blood pressure, reduces the need for rescue interventions, and is well tolerated with few side effects. 12, 13, 14, 15

Advanced Hemodynamic Strategies

• Isothermic dialysis: Maintaining the patient’s predialysis body temperature throughout treatment reduces intradialytic morbid events by ≈ 25 % in patients prone to hypotension. 10, 11
• Thermoneutral dialysis: Preventing any thermal energy exchange between dialysate and extracorporeal circuit helps preserve hemodynamic stability. 11

Adjunctive Therapy for Refractory Cases

• Albumin infusion: In hospitalized patients with serum albumin < 30 g/L, 25 % albumin (vs. saline) improves hypotension, raises the lowest intradialytic systolic blood pressure, and permits higher ultrafiltration rates; however, the annual cost (~ $20,000 per patient for thrice‑weekly dosing) limits routine use, and alternatives such as midodrine, higher dialysate calcium, or cooler dialysate should be prioritized. 17